D-104-2013 Class II Terminated
FDA drug recall D-104-2013 was initiated by Alara Pharmaceutical Co on October 29, 2012 and is designated Class II. Reason for recall: Subpotent; 15 month stability The recall status is terminated (terminated January 3, 2014). Affected quantity: 7,432 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- January 2, 2013
- Initiation Date
- October 29, 2012
- Termination Date
- January 3, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,432 bottles
Product Description
Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR
Reason for Recall
Subpotent; 15 month stability
Distribution Pattern
Nationwide
Code Information
11T7011A, Exp. Date: 12/2012